The global digital pcr market size was surpassed at $508.82 million in 2020, and it is expected to hit US$ 1,305.30 million by 2030, growing at a CAGR of 8.6% from 2021 to 2030.
The global digital pcr market size was surpassed at $508.82 million in 2020, and it is expected to hit US$ 1,305.30 million by 2030, growing at a CAGR of 8.6% from 2021 to 2030.
Digital PCR is an end-point PCR method, which is used for absolute quantification and for analysis of minority sequences against a background of similar majority sequences. Digital PCR (dPCR) enables precise, highly sensitive quantification of nucleic acids. Traditional PCR is an end-point analysis that is semi-quantitative as the amplified product is detected by agarose gel electrophoresis. Real-time PCR (or qPCR) uses fluorescence-based detection to allow the measurement of accumulated amplified product as the reaction progresses. qPCR requires normalization to controls or to a standard curve, allowing only relative quantification. Furthermore, variations in amplification efficiency may affect qPCR results. The digital PCR (dPCR) is mainly classified as droplet digital PCR, chip based digital PCR, and beaming digital PCR.
Full Report is Ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112632
The growth of the global digital polymerase chain reaction market is majorly driven by the increase in prevalence of different types of cancers such as lung cancer, blood cancer, and brain tumor. Digital PCR test is used for molecular diagnosis of cancer. For instance, as per the Globocan 2020, lung cancer is a second ranked cancer in terms of patient count in Europe with estimated 477,534 newly diagnosed patients. Moreover, advantages of digital PCR over traditional PCR technology such as real time polymerase chain reaction (RT PCR) and quantitative polymerase chain reaction (qPCR) are expected to fuel their adoption in the digital PCR market analysis period. Furthermore, surge in healthcare expenditure of peoples in developing countries and surge in demand for accurate molecular diagnosis of disease drive the digital PCR market growth.
In addition, surge of COVID-19 pandemic contributes to the growth of digital PCR market share. The advanced digital PCR devices are used as molecular diagnosis tool for detection of COVID-19 infections. For instance, according to World Health Organization (WHO), as of December 2021, around 273 million cases are diagnosed and approximately 5.3 million deaths have been reported globally due to COVID-19. Furthermore, digital PCR devices are used in R&D activities in pharmaceutical sector.
Moreover, advancement in digital PCR technology and rise in number of product launch in the global market are anticipated to contribute toward the growth of the digital PCR industry. For instance, in June 2021, Bio-Rad Laboratories, Inc., one of the global leaders in life science sector, announced the launch of PREvalenceddPCR SARS-CoV-2 wastewater quantification kit for COVID-19 wastewater testing.
Furthermore, the surge in R&D activities for advancement in PCR technology and increase in collaboration agreements between companies for development of digital PCR boosts the growth of digital PCR industry. For instance, in January 2022, Qiagen, a leading developer of diagnostic devices, entered in collaboration with AtilaBioSystems and Actome GmbH to provide non-invasive prenatal testing (NIPT) solutions to QIAGEN’s dPCR and licensing & co-marketing agreement. However, high cost of digital PCR devices and reimbursement issues with digital PCR devices impede the growth of this market.
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112632/2900
Digital PCR market segmentation
The digital PCR market size is segmented on the basis of technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others.
As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations.
By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
Depending on technology, the droplet digital PCR (ddPCR) segment dominated the market in 2020, and this trend is expected to continue during the forecast period owing to rise in prevalence of infectious diseases. However, the chip based digital PCR segment is expected to witness considerable growth during the forecast period due to advancement in chip based digital PCR technology.
On the basis of product type, the digital PCR systems segment dominated the market in 2020, and this trend is expected to continue during the forecast period owing to rise in demand for molecular diagnostics in personalized medicine and new product launch. However, the consumables & reagents segment is expected to witness considerable growth during the digital PCR market forecast period due to surge in demand for early diagnosis and increase in number of key players to manufacture consumable and reagents for digital PCR.
By application, the pharmaceuticals & biotechnology industries segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period owing to rise in number of cancer patients. However, the clinical diagnostic laboratories segment is expected to witness considerable growth during the forecast period due to increase in number of clinical research centers and rise in number of clinical trials.
By region, North America garnered the major share in the digital PCR market in 2020, and is expected to dominate the global market during the forecast period owing to rise in prevalence of cancer, presence of key players for development of digital PCR devices, and well-established infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR of 10.6% from 2021 to 2030 owing to an increase in the number of hospitals, prevalence of cancer, and high population base.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digital pcr market size analysis from 2020 to 2030 to identify the prevailing digital PCR market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digital pcr market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digital pcr market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
- BY TECHNOLOGY
- Droplet Digital Pcr
- Chip Based Digital Pcr
- Beaming Digital Pcr
- BY PRODUCT TYPE
- igitalPcr Systems
- Consumables And Reagents
- Software And Services
- BY APPLICATION
- Clinical Diagnostics
- Forensic And Others
- Research
- BY END USER
- Pharmaceuticals And Biotechnology Industries
- Clinical Diagnostic Laboratories
- Universities And Other Organizations
- BY REGION
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
Key Market Players
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- jnmedsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- STILLA TECHNOLOGIES
- sysmex corporation
- Thermo Fisher Scientific, Inc.
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112632/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/